
Deep-Science Biotech University Spin-Out
Raising Finance
Context
Eddyline Ventures partnered with an early-stage biotech PaaS (Platform as a Service) spin-out from a leading UK university aiming to transform mental healthcare with innovative biomarker discovery and AI-driven analytics.
Approach
We provided strategic clarity, facilitated investor engagement, secured angel investment alongside a Biomedical Catalyst grant, and integrated agile operational guidance.
Outcome
The spin-out secured crucial early-stage funding, delivered its neuroscience project, and is now positioned for the next funding round and strategic scalability.